A ONECUT1 regulatory, non-coding region in pancreatic development and diabetes

Sarah Merz,Valérie Senée,Anne Philippi,Franz Oswald,Mina Shaigan,Marita Führer,Cosima Drewes,Chantal Allgöwer,Rupert Öllinger,Martin Heni,Anne Boland,Jean-François Deleuze,Franziska Birkhofer,Eduardo G. Gusmao,Martin Wagner,Meike Hohwieler,Markus Breunig,Roland Rad,Reiner Siebert,David Alexander Christian Messerer,Ivan G. Costa,Fernando Alvarez,Cécile Julier,Alexander Kleger,Sandra Heller
DOI: https://doi.org/10.1016/j.celrep.2024.114853
IF: 8.8
2024-10-20
Cell Reports
Abstract:Merz et al. identify a disease-causing deletion upstream of ONECUT1. They uncover a cis-acting enhancer that regulates ONECUT1 expression during pancreatic development, harboring a low-frequency variant associated with type 2 diabetes. Additionally, they provide clinical relevance by experimentally testing in vitro therapeutic options for affected patients.
cell biology
What problem does this paper attempt to address?